Diebold Nixdorf

DBD · NYSE

$67.84+$0.27 (+0.40%)TodayMarket closed · Oct 20, 6:30 PM ET

Prev close $67.57

DBD analyst rating

BuyConsensus of 3 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy3
Hold0
Underperform0
Sell0

12-month price target · 4 analysts

Average $100.30 (+47.8% upside)

Low: $95.95
Now: $67.84
High: $105.00

Upgrades and downgrades

The latest rating actions, newest first

DBD analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Wedbush	Oct 15, 2026	Maintains	Outperform	$100.00	72%
DA Davidson	May 4, 2026	Maintains	Buy	$100.00	72%
DA Davidson	Apr 21, 2026	Maintains	Buy	$100.00	72%
DA Davidson	Feb 13, 2026	Maintains	Buy	$80.00 → $100.00	72%
Wedbush	Feb 13, 2026	Maintains	Outperform	$80.00 → $100.00	25%
Wedbush	Feb 9, 2026	Maintains	Outperform	$80.00	25%
Wedbush	Nov 18, 2025	Maintains	Outperform	$80.00	25%
Wedbush	Nov 6, 2025	Maintains	Outperform	$70.00 → $80.00	25%
Wedbush	Oct 28, 2025	Maintains	Outperform	$70.00	25%

The case for and against

Updated Oct 17, 2026

Bull case

Diebold Nixdorf is supported by a resilient core business in Banking and an accelerating Retail recovery, with healthy order entry, backlog of $790M, and multiple win cycles in ATM, ePOS, and SCO that broaden its revenue base. Its fundamental outlook is strengthened by improving profitability and cash generation, including 2026 EBITDA guidance of $510M-$535M, expected FCF at 50%+ of EBITDA, and net leverage of just 1.2x, which together provide flexibility for buybacks and refinancing. Execution on lean cost actions, better price capture, and a strong installed base in global ATM and retail automation markets should sustain margin expansion and make its valuation appear undemanding relative to improving 2026 and 2027 fundamentals.

Bear case

Diebold Nixdorf is facing a fundamentally challenged outlook because falling demand for ATMs, intensifying competition from alternative products, and pricing pressure from other vendors threaten both revenue growth and margins. Although inventories rose and quote time frames shortened, the company has not fully modeled higher ASPs, revenues, or operating margin dollars, while tariff, trade, FX, and supply-chain disruptions could further erode profitability and delay installations and service. Liquidity is also fragile, with only about 150K shares traded daily, roughly $7M of daily liquidity, and debtholders controlling approximately 60% of common shares, creating overhang risk if ownership shifts.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.